MedPath

Sodium Fluoride

These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection, USP safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injection, USP. SODIUM FLUORIDE F 18 INJECTION, USPFor Intravenous UseInitial U.S. Approval: 2014

Approved
Approval ID

f8afb06c-f4c3-46f0-8f8b-0bc9e072ce47

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 11, 2019

Manufacturers
FDA

THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH

DUNS: 110565913

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Fluoride F 18

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code13267-542
Application NumberANDA204328
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Fluoride F 18
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 11, 2019
FDA Product Classification

INGREDIENTS (2)

SODIUM FLUORIDE F-18Active
Quantity: 600 mCi in 1 mL
Code: 9L75099X6R
Classification: ACTIM
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Fluoride - FDA Drug Approval Details